2-Chloropyrimidine-5-carboxylic Acid: Technical Guide & Application Insights
Table of Contents
1. Product Overview & Specifications
Chemical Name: 2-Chloropyrimidine-5-carboxylic Acid
CAS No: 37407-65-7
Molecular Formula: C5H3ClN2O2
Purity: ≥98% (HPLC)
Appearance: White to off-white crystalline powder
Comparative Analysis
| Parameter | Our Product | Industry Standard |
|---|---|---|
| Purity Level | 98-99.5% | 95-97% |
| Chlorine Content | 21.8-22.2% | 20.5-21.5% |
| Solubility | DMSO: 50 mg/mL | DMSO: 30 mg/mL |
2. Key Applications & Industrial Uses
Pharmaceutical Intermediates
Widely utilized in synthesizing kinase inhibitors and antiviral agents, particularly in:
- EGFR tyrosine kinase inhibitor development
- HIV protease inhibitor precursors
- Oncology drug candidates
Agrochemical Synthesis
Essential component for:
- Herbicide metabolites
- Fungicidal compound prototyping
3. Operational Guidelines & Best Practices
Storage Protocols
- Store at 2-8°C in sealed containers
- Protect from light and moisture
Reaction Optimization
Recommended conditions for amidation reactions:
- Temperature: 0-5°C (initial stage)
- Coupling Agents: HATU/DIPEA system
- Reaction Time: 4-6 hours
4. Real-World Application Cases
Case Study 1: Antiviral Drug Development
Used as key intermediate in remdesivir analogue synthesis achieving 92% yield in:
- Nucleoside phosphoramidate conjugation
- Viral RNA polymerase inhibition trials
5. Client Success Stories
PharmaTech Solutions (Germany)
Integrated our product into their kinase inhibitor pipeline:
- Reduced synthesis steps from 7 to 4
- Increased batch consistency from ±8% to ±2%
- Achieved 30% cost reduction in lead optimization
AgroChem China Co., Ltd
Utilized in novel fungicide development:
- Enhanced bioactivity by 40% vs previous formulations
- Met EU REACH compliance requirements
6. Technical Consultation & Inquiry
Contact our technical team for:
- Custom synthesis protocols
- Bulk order specifications
- Regulatory support documentation
Email: info@vivalr.com
Phone: (86) 15866781826


评论
目前还没有评论。